NasdaqGS:NH

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

NantHealth, Inc., together with its subsidiaries, operates as a healthcare technology company converging science and technology in the United States, the United Kingdom, Singapore, and Canada. More Details


Snowflake Analysis

Slightly overvalued with concerning outlook.


Similar Companies

Share Price & News

How has NantHealth's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: NH's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

-2.5%

NH

0.6%

US Healthcare Services

-1.2%

US Market


1 Year Return

207.8%

NH

76.9%

US Healthcare Services

19.5%

US Market

Return vs Industry: NH exceeded the US Healthcare Services industry which returned 76.7% over the past year.

Return vs Market: NH exceeded the US Market which returned 19.9% over the past year.


Shareholder returns

NHIndustryMarket
7 Day-2.5%0.6%-1.2%
30 Day-9.2%11.5%5.8%
90 Day-47.7%11.5%8.1%
1 Year207.8%207.8%77.4%76.9%22.3%19.5%
3 Year-39.7%-39.7%115.1%113.5%43.6%34.0%
5 Yearn/a177.3%174.4%87.3%66.1%

Price Volatility Vs. Market

How volatile is NantHealth's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is NantHealth undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: NH ($2.37) is trading below our estimate of fair value ($9.77)

Significantly Below Fair Value: NH is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: NH is unprofitable, so we can't compare its PE Ratio to the US Healthcare Services industry average.

PE vs Market: NH is unprofitable, so we can't compare its PE Ratio to the US market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate NH's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: NH has negative assets, so we can't compare its PB Ratio to the US Healthcare Services industry average.


Next Steps

Future Growth

How is NantHealth forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?

33.0%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: NH is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: NH is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: NH is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: NH's revenue (10.1% per year) is forecast to grow faster than the US market (10% per year).

High Growth Revenue: NH's revenue (10.1% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: NH is forecast to be unprofitable in 3 years.


Next Steps

Past Performance

How has NantHealth performed over the past 5 years?

-1.3%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: NH is currently unprofitable.

Growing Profit Margin: NH is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: NH is unprofitable, and losses have increased over the past 5 years at a rate of 1.3% per year.

Accelerating Growth: Unable to compare NH's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: NH is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (-4.8%).


Return on Equity

High ROE: NH's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Next Steps

Financial Health

How is NantHealth's financial position?


Financial Position Analysis

Short Term Liabilities: NH has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Long Term Liabilities: NH has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Debt to Equity History and Analysis

Debt Level: NH has negative shareholder equity, which is a more serious situation than a high debt level.

Reducing Debt: NH's has negative shareholder equity, so we do not need to check if its debt has reduced over time.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: NH has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if NH has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Next Steps

Dividend

What is NantHealth current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate NH's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate NH's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if NH's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if NH's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of NH's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

3.0yrs

Average management tenure


CEO

Patrick Soon-Shiong (67 yo)

10.25yrs

Tenure

Dr. Patrick Soon-Shiong, M.D., FRCS (C), FACS, MBBCh, MSc, FRCS (C), is an Owner of Los Angeles Times Communications, LLC. Dr. Soon-Shiong is a physician, surgeon and scientist, invented and developed the ...


Leadership Team

NamePositionTenureCompensationOwnership
Patrick Soon-Shiong
Founder10.25yrsno datano data
Bob Petrou
Chief Financial Officer2.08yrsUS$685.07k0.12%
$ 325.9k
Ronald Louks
Chief Operating Officer3.42yrsUS$928.33k0.28%
$ 724.9k
Brandon Villery
Senior VP & General Counsel3yrsno datano data
Mark Mozley
Senior VP of Global Sales & Marketing1.75yrsno datano data
Maureen Becker
Senior Vice President of Human Resources2.67yrsno datano data
Sandeep Reddy
Chief Medical Officer3.42yrsno datano data
Keith Krebs
Senior Vice President of Client Services3yrsno datano data
Chris House
Senior Vice President of Product Management & Development3yrsno datano data

3.0yrs

Average Tenure

55yo

Average Age

Experienced Management: NH's management team is considered experienced (3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Patrick Soon-Shiong
Founder10.25yrsno datano data
Michael Blaszyk
Independent Director4.42yrsUS$184.12k0.13%
$ 352.6k
Kirk Calhoun
Independent Director4.42yrsUS$177.24k0.13%
$ 352.6k
Michael Sitrick
Independent Director4.42yrsUS$176.88k0.13%
$ 352.6k
Deanna Wise
Independent Director0.58yrno datano data

4.4yrs

Average Tenure

68yo

Average Age

Experienced Board: NH's board of directors are considered experienced (4.4 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

NantHealth, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: NantHealth, Inc.
  • Ticker: NH
  • Exchange: NasdaqGS
  • Founded: 2010
  • Industry: Health Care Technology
  • Sector: Healthcare
  • Market Cap: US$263.127m
  • Shares outstanding: 111.02m
  • Website: https://nanthealth.com

Number of Employees


Location

  • NantHealth, Inc.
  • 9920 Jefferson Boulevard
  • Culver City
  • California
  • 90232
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
NHNasdaqGS (Nasdaq Global Select)YesCommon SharesUSUSDJun 2016
NELDB (Deutsche Boerse AG)YesCommon SharesDEEURJun 2016

Biography

NantHealth, Inc., together with its subsidiaries, operates as a healthcare technology company converging science and technology in the United States, the United Kingdom, Singapore, and Canada. It provides ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/10/19 06:00
End of Day Share Price2020/10/16 00:00
Earnings2020/06/30
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.